Have been wathcing this one closely now for a few days, so hard to know whether it will fall or has stabalised at these prices.Buyers slowly building, but one or two sellers hanging about.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%